As of April 2025 Innate Pharma has a market cap of HK$1.31 Billion. This makes Innate Pharma the world's 8351th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Apr 26th, 2025 the market cap of Innate Pharma was reported to be: